Research Offers Hope for Preventing Post-COVID ‘Brain Fog’ by Targeting Brain’s Blood Vessels
https://reachmd.com/news/research-offers-hope-for-preventing-post-covid-brain-fog-by-targeting-brains-blood-vessels/2462399/
Among the many confounding symptoms in patients recovering from a COVID-19 infection are memory loss and difficulty learning. Yet little is known about the mechanisms of cognitive impairments like these, commonly called brain fog. In a new study, researchers at the University of Illinois Chica…
Special Gel Could Help in Surgery After Pelvic Organ Prolapse
https://reachmd.com/news/special-gel-could-help-in-surgery-after-pelvic-organ-prolapse/2457366/
Credit: Ivan Samkoz/Pexels Of women who have had surgery for pelvic organ prolapse, 20% require surgery again. This is usually due to suboptimal wound healing after surgery. The synthetic PIC gel (dis…
Pennington Biomedical Seeks to Enhance Lifespan, Health in Aging
https://reachmd.com/news/pennington-biomedical-seeks-to-enhance-lifespan-health-in-aging/2457266/
The Pennington Biomedical Research Center is discovering new ways to improve life span and health during aging through its research.A new study from Pennington Biomedical, "Restricting bioenergetic efficiency enhances longevity and mitochondrial redox capacity in Drosophila melanogaster," publishe…
A New Approach Can Address Antibiotic Resistance to Mycobacterium Abscessus
https://reachmd.com/news/a-new-approach-can-address-antibiotic-resistance-to-mycobacterium-abscessus/2456781/
Overcoming efflux to make a more effective antibiotic Through their work, the scientists unraveled the mechanism of action by which eAmSPCs are more effective: they circumvent efflux. Efflux is the process that cells use to get rid of a drug — imagine pumping water out of a flooded basement— …
Potent and Highly Selective CDK9 Inhibitor for Treatment of Hematologic Malignancies
https://reachmd.com/news/potent-and-highly-selective-cdk9-inhibitor-for-treatment-of-hematologic-malignancies/2456717/
by Impact Journals LLC Effect of GFH009 treatment on CDK9-dependent prote…
Nematode Proteins Shed Light on Infertility
https://reachmd.com/news/nematode-proteins-shed-light-on-infertility/2456728/
We have two copies of each chromosome in every cell in our bodies except in our reproductive cells. Sperm and egg cells contain a single copy of each chromosome with a unique mix of genes from our parents, an evolutionary trick to give our offspring genetic variability. The sperm and eg…
EHA 2024: Monoclonal Antibodies Continue to Dominate Multiple Myeloma Treatments
https://reachmd.com/news/eha-2024-monoclonal-antibodies-continue-to-dominate-multiple-myeloma-treatments/2467248/
Many significant Phase I-III studies targeting haematological malignancies, such as multiple myeloma (MM), were presented at the European Hematology Association Hybrid Congress 2024 (EHA 2024), which took place from 13 – 16 June. MM is the third most prevalent blood cancer worldwide. According to…
Gotta Go? New Bladder Device Lets You Know
https://reachmd.com/news/gotta-go-new-bladder-device-lets-you-know/2462464/
Should you run to the bathroom now? Or can you hold it until you get home? A new implant and associated smartphone app may someday remove the guess work from the equation.Northwestern University researchers have developed a new soft, flexible, battery-free implant that atta…
Philips Debuts Latest Advances in OB/GYN Ultrasound to Enhance Early Detection and Diagnostic Confidence at ISUOG 2023
https://reachmd.com/news/philips-debuts-latest-advances-in-obgyn-ultrasound-to-enhance-early-detection-and-diagnostic-confidence-at-isuog-2023/2456687/
Approximately 1.9 million stillbirths – babies born with no sign of life at 28 weeks of pregnancy or later – occurred worldwide in 2021. According to the latest data, 1 in 72 total births globally resulted in a stillborn baby, or one every 17 seconds [1]. Additionally, an estimated 240,000 newbor…
New Findings on Immune Response to Initial COVID Vaccine
https://reachmd.com/news/new-findings-on-immune-response-to-initial-covid-vaccine/2462317/
PHILADELPHIA – Antibody responses to new SARS-CoV-2 variant infections and vaccinations are powerfully shaped by prior exposures to earlier SARS-CoV-2 vaccines, according to a new study from the Perelman School of Medicine at the University of Pennsylvania. In the study, published…